Syndax Pharmaceuticals (SNDX) Change in Inventory (2024 - 2026)
Syndax Pharmaceuticals (SNDX) posted quarterly Change in Inventory of $2.1 million for Q1 2026, down 50.85% year-over-year from $4.2 million in Q1 2025, and down 73.59% quarter-over-quarter from $7.8 million in Q4 2025.
Syndax Pharmaceuticals (SNDX) Change in Inventory (2024 - 2026) Analysis & Trends
Syndax Pharmaceuticals' Change in Inventory history runs 3 years deep, the most recent figure standing at $2.1 million for Q1 2026.
- In Q1 2026, Change in Inventory fell 50.85% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $30.0 million (up 557.45% YoY), while the FY2025 annual figure was $32.1 million, up 8668.03% from the prior year.
- Change in Inventory for Q1 2026 stood at $2.1 million, down from $7.8 million in the prior quarter.
- The five-year high for Change in Inventory was $12.9 million in Q2 2025, with the low at $366000.0 in Q4 2024.
- The 3-year median for Change in Inventory is $5.7 million (2025), against an average of $5.8 million.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory jumped 2031.42% in 2025, then slumped 50.85% in 2026.
- Syndax Pharmaceuticals' Change in Inventory stood at $366000.0 in 2024, then surged by 2031.42% to $7.8 million in 2025, then sank by 73.59% to $2.1 million in 2026.
- Business Quant data shows SNDX's Change in Inventory at $2.1 million in Q1 2026, $7.8 million in Q4 2025, and $7.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn | -1.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.84 Mn |
| Jun 30, 2026 | -1.84 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Mar 31, 2026 | 2.06 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Dec 31, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.18 Mn |
| Sep 30, 2025 | 7.18 Mn |
| Jun 30, 2025 | 12.92 Mn |
| Jun 30, 2025 | 12.92 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Mar 31, 2025 | 4.19 Mn |
| Dec 31, 2024 | 366,000.00 |
| Dec 31, 2024 | 366,000.00 |